The absence of a protein that activates the body’s antiviral defenses can cause a rare rheumatoid-like autoinflammatory condition that is treatable with an FDA-approved class of drugs known as TNF (tumor necrosis factor) inhibitors, researchers have found.
Click here for original story, Researchers uncover the biology and treatment behind a rare autoinflammatory disease
Source: ScienceDaily